Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Amortization of Deferred Charges: 2019-2021

Historic Amortization of Deferred Charges for Foghorn Therapeutics (FHTX) over the last 3 years, with Dec 2021 value amounting to $318,000.

  • Foghorn Therapeutics' Amortization of Deferred Charges fell 1.69% to $58,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $318,000, marking a year-over-year increase of 33.61%. This contributed to the annual value of $318,000 for FY2021, which is 33.61% up from last year.
  • As of FY2021, Foghorn Therapeutics' Amortization of Deferred Charges stood at $318,000, which was up 33.61% from $238,000 recorded in FY2020.
  • Foghorn Therapeutics' Amortization of Deferred Charges' 5-year high stood at $318,000 during FY2021, with a 5-year trough of $99,000 in FY2019.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $238,000 (2020), whereas its average is $218,333.
  • Data for Foghorn Therapeutics' Amortization of Deferred Charges shows a peak YoY spiked of 140.40% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Foghorn Therapeutics' Amortization of Deferred Charges stood at $99,000 in 2019, then soared by 140.40% to $238,000 in 2020, then surged by 33.61% to $318,000 in 2021.